Literature DB >> 2985645

Immune response to bovine herpes herpesvirus type 1 infections: virus-specific antibodies in sera from infected animals.

J K Collins, A C Butcher, C A Riegel.   

Abstract

The virus specificity of antibodies against bovine herpes virus type 1 was determined with a radioimmunoprecipitation assay and serum collected from natural and experimentally induced infections. By using sequentially collected sera, the development of antibodies to 4 to 5 viral glycoproteins and 11 to 12 nonglycosylated proteins was followed for the first 50 days after infection. The major and most consistent responses in experimentally and naturally infected animals were to four glycoproteins with molecular weights of 102,000, 96,000, 69,000, and 55,000, as well as to a major virion 115,000-molecular-weight nonglycosylated protein. The four glycoproteins were all coprecipitated by a neutralizing monoclonal antibody and were probably involved as target antigens in virus neutralization. Another antigenically unrelated glycoprotein with a molecular weight of 82,000 and a nonglycosylated protein with a molecular weight of 91,000 were also precipitated, but the immune response to these two proteins was transient. Reactivity to gp82 was only weakly detected in serum from naturally infected animals. Contact control animals which did not contract a bovine herpes virus type 1 infection but were exposed to infected animals with signs of severe illness had antibodies which recognized gp102, gp96, gp69 and gp55 as well as p115. These antibodies were present in low amounts and, in contrast to infected animals, did not increase between acute and convalescent sampling.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985645      PMCID: PMC271716          DOI: 10.1128/jcm.21.4.546-552.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells.

Authors:  B T Rouse; L A Babiuk
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

2.  Role of cell-mediated immunity in the recovery of cattle from primary and recurrent infections with infectious bovine rhinotracheitis virus.

Authors:  D H Davies; L E Carmichael
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

3.  Bovine herpesvirus IBR-IPV. The antibody virus neutralization reaction.

Authors:  J A House; J A Baker
Journal:  Cornell Vet       Date:  1971-04

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Herpesvirus-induced "early" glycoprotein: characterization and possible role in immune cytolysis.

Authors:  V Misra; J E Gilchrist; G Weinmaster; L Qualtiere; S Van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

7.  Antibody dependent cytotoxicity mediated by neutrophils: a possible mechanism of antiviral defense.

Authors:  R C Wardley; B T Rouse; L A Babiuk
Journal:  J Reticuloendothel Soc       Date:  1976-05

8.  Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis.

Authors:  L A Babiuk; R C Wardley; B T Rouse
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Identification of envelope and nucleocapsid proteins of infectious bovine rhinotracheitis virus by SDS-polyacrylamide gel electrophoresis.

Authors:  D C Bolton; Y C Zee; A A Ardans
Journal:  Vet Microbiol       Date:  1983-02       Impact factor: 3.293

10.  The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle.

Authors:  K W Jericho; L A Babiuk
Journal:  Can J Comp Med       Date:  1983-04
View more
  13 in total

1.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Rapid, sensitive, competitive serologic enzyme-linked immunosorbent assay for detecting serum antibodies to bovine herpesvirus type 1.

Authors:  C A Riegel; V K Ayers; J K Collins
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

3.  Temporal control of bovine herpesvirus 1 glycoprotein synthesis.

Authors:  G V Ludwig; G J Letchworth
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

Review 4.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

5.  Monoclonal antibodies that distinguish between encephalitogenic bovine herpesvirus type 1.3 and respiratory bovine herpesvirus type 1.1.

Authors:  C S Chung; L D Pearson; V K Ayers; J K Collins
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

6.  Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1.

Authors:  J J Carter; A D Weinberg; A Pollard; R Reeves; J A Magnuson; N S Magnuson
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virus.

Authors:  S van Drunen Littel-van den Hurk; T Zamb; L A Babiuk
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

8.  Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; T J Zamb; J V van den Hurk; M Campos; R Harland; L A Babiuk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Production, purification and characterization of polyclonal antibody against the truncated gK of the duck enteritis virus.

Authors:  Shunchuan Zhang; Jun Xiang; Anchun Cheng; Mingshu Wang; Xin Li; Lijuan Li; Xiwen Chen; Dekang Zhu; Qihui Luo; Xiaoyue Chen
Journal:  Virol J       Date:  2010-09-17       Impact factor: 4.099

10.  Expressing gK gene of duck enteritis virus guided by bioinformatics and its applied prospect in diagnosis.

Authors:  Shunchuan Zhang; Guangpeng Ma; Jun Xiang; Anchun Cheng; Mingshu Wang; Dekang Zhu; Renyong Jia; Qihui Luo; Zhengli Chen; Xiaoyue Chen
Journal:  Virol J       Date:  2010-07-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.